Daniel Knappe

3.0k total citations
63 papers, 2.5k citations indexed

About

Daniel Knappe is a scholar working on Microbiology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Daniel Knappe has authored 63 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Microbiology, 41 papers in Molecular Biology and 14 papers in Molecular Medicine. Recurrent topics in Daniel Knappe's work include Antimicrobial Peptides and Activities (42 papers), Antibiotic Resistance in Bacteria (14 papers) and Biochemical and Structural Characterization (11 papers). Daniel Knappe is often cited by papers focused on Antimicrobial Peptides and Activities (42 papers), Antibiotic Resistance in Bacteria (14 papers) and Biochemical and Structural Characterization (11 papers). Daniel Knappe collaborates with scholars based in Germany, Australia and United States. Daniel Knappe's co-authors include Ralf Hoffmann, Roland Böttger, Norbert Sträter, Andor Krizsan, Daniela Volke, Nicole Berthold, Michael Zahn, Lisandra L. Martin, Stefanie Weinert and Stefania Piantavigna and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Daniel Knappe

63 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Knappe Germany 28 1.7k 1.5k 328 263 251 63 2.5k
Yuxin Chen China 25 2.4k 1.4× 2.2k 1.5× 482 1.5× 85 0.3× 115 0.5× 67 3.5k
John P. Mueller United States 26 1.0k 0.6× 454 0.3× 429 1.3× 527 2.0× 212 0.8× 54 2.5k
Frederick Harris United Kingdom 28 1.7k 1.0× 1.3k 0.9× 327 1.0× 57 0.2× 73 0.3× 84 2.5k
Song Yub Shin South Korea 42 3.5k 2.1× 3.3k 2.3× 962 2.9× 145 0.6× 107 0.4× 168 4.9k
Xiaoxing Luo China 25 1.2k 0.7× 403 0.3× 227 0.7× 350 1.3× 113 0.5× 69 2.1k
Hervé Le Moual Canada 23 1.0k 0.6× 365 0.2× 188 0.6× 291 1.1× 111 0.4× 36 2.1k
Chiara Falciani Italy 28 1.3k 0.8× 817 0.6× 227 0.7× 172 0.7× 78 0.3× 83 2.1k
Xurui Cheng China 7 1.3k 0.8× 658 0.4× 191 0.6× 55 0.2× 89 0.4× 9 2.0k
Elke K. H. Schweda Sweden 30 1.3k 0.8× 859 0.6× 315 1.0× 65 0.2× 704 2.8× 76 2.5k

Countries citing papers authored by Daniel Knappe

Since Specialization
Citations

This map shows the geographic impact of Daniel Knappe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Knappe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Knappe more than expected).

Fields of papers citing papers by Daniel Knappe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Knappe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Knappe. The network helps show where Daniel Knappe may publish in the future.

Co-authorship network of co-authors of Daniel Knappe

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Knappe. A scholar is included among the top collaborators of Daniel Knappe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Knappe. Daniel Knappe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spiegeleer, Anton De, Evelien Wynendaele, Marta Planas, et al.. (2024). Streptococcal quorum sensing peptide CSP-7 contributes to muscle inflammation and wasting. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167094–167094. 4 indexed citations
2.
Knappe, Daniel, et al.. (2020). Proline-rich antimicrobial peptide Api137 is bactericidal in porcine blood infected ex vivo with a porcine or human Klebsiella pneumoniae strain. Journal of Global Antimicrobial Resistance. 24. 127–135. 7 indexed citations
3.
Almaaytah, Ammar, et al.. (2018). Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine. Pharmaceuticals. 11(1). 3–3. 42 indexed citations
4.
Rubner, Stefan, et al.. (2018). iSPAAC: Isomer‐Free Generation of a Bcl‐xL‐Inhibitor in Living Cells. Chemistry - A European Journal. 24(52). 13762–13766. 7 indexed citations
5.
Böttger, Roland, Ralf Hoffmann, & Daniel Knappe. (2017). Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum. PLoS ONE. 12(6). e0178943–e0178943. 230 indexed citations
6.
Шамова, О. В., Д. С. Орлов, Sergey V. Balandin, et al.. (2016). Minibactenecins ChBac7.Nα and ChBac7. Nβ - Antimicrobial Peptides from Leukocytes of the Goat Capra hircus.. Acta Naturae. 8(3). 136–146. 23 indexed citations
7.
Schneider, Viktoria A. F., I. Schäfer, Stefania Piantavigna, et al.. (2016). N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa. Frontiers in Cell and Developmental Biology. 4. 39–39. 15 indexed citations
8.
Knappe, Daniel, Knut Adermann, & Ralf Hoffmann. (2015). Oncocin Onc72 is efficacious against antibiotic‐susceptible Klebsiella pneumoniae ATCC 43816 in a murine thigh infection model. Biopolymers. 104(6). 707–711. 27 indexed citations
9.
Knappe, Daniel, Serge Ruden, Ralf Mikut, et al.. (2015). Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus. Amino Acids. 48(1). 269–280. 35 indexed citations
10.
Singer, David, et al.. (2015). Immunogenicity and Pharmacokinetics of Short, Proline-Rich Antimicrobial Peptides. Future Medicinal Chemistry. 7(12). 1581–1596. 16 indexed citations
11.
Knappe, Daniel, et al.. (2015). Development of Bifunctional Inhibitors of Polo‐Like Kinase 1 with Low‐Nanomolar Activities Against the Polo‐Box Domain. ChemBioChem. 17(8). 759–767. 21 indexed citations
12.
Stalmans, Sofie, Evelien Wynendaele, Nathalie Bracke, et al.. (2014). Blood-Brain Barrier Transport of Short Proline-Rich Antimicrobial Peptides. Protein and Peptide Letters. 21(4). 399–406. 33 indexed citations
13.
Zahn, Michael, et al.. (2014). Structural Identification of DnaK Binding Sites within Bovine and Sheep Bactenecin Bac7. Protein and Peptide Letters. 21(4). 407–412. 28 indexed citations
14.
Knappe, Daniel, Marco Cassone, Friederike I. Nollmann, László Ötvös, & Ralf Hoffmann. (2014). Hydroxyproline Substitutions Stabilize Non-Glycosylated Drosocin Against Serum Proteases Without Challenging its Antibacterial Activity. Protein and Peptide Letters. 21(4). 321–329. 10 indexed citations
15.
Ötvös, László, Stefan W. Vetter, Daniel Knappe, et al.. (2013). The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor. Amino Acids. 46(4). 873–882. 17 indexed citations
16.
Zahn, Michael, et al.. (2013). Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK. Journal of Molecular Biology. 425(14). 2463–2479. 102 indexed citations
17.
Czihal, Patricia, Daniel Knappe, Michael Zahn, et al.. (2012). Api88 Is a Novel Antibacterial Designer Peptide To Treat Systemic Infections with Multidrug-Resistant Gram-Negative Pathogens. ACS Chemical Biology. 7(7). 1281–1291. 96 indexed citations
18.
19.
Ötvös, László, Eva Regina Haspinger, Francesca La Russa, et al.. (2011). Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnology. 11(1). 90–90. 149 indexed citations
20.
Knappe, Daniel, Stefania Piantavigna, Anne Maria Kaldal Hansen, et al.. (2010). Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): A Novel Antibacterial Peptide Optimized against Gram-Negative Human Pathogens. Journal of Medicinal Chemistry. 53(14). 5240–5247. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuxin Chen Breakdown of academic impact, for papers by John P. Mueller Breakdown of academic impact, for papers by Frederick Harris Breakdown of academic impact, for papers by Song Yub Shin Breakdown of academic impact, for papers by Xiaoxing Luo Breakdown of academic impact, for papers by Hervé Le Moual Breakdown of academic impact, for papers by Chiara Falciani Breakdown of academic impact, for papers by Xurui Cheng Breakdown of academic impact, for papers by Elke K. H. Schweda
Rankless by CCL
2026